For angiogenesis to occur, endothelial cells must escape their stable location and break through the basement membrane. Cells migrate toward an angiogenic stimulus that may be released from nearby tumor cells. These cells proliferate to form new blood vessels.

Our Endothelial Tube Formation Assay (In Vitro Angiogenesis) provides an easy, robust system to assess angiogenesis in vitro. The ECM gel matrix very closely resembles an in vivo environment.

1. Kimura, T. et al. (2011). P2y5/LPA6 Attenuates LPA1-Mediated VE-Cadherin Translocation and Cell-Cell Dissociation through G12/13 Protein-Src-Rap1. Cardiovasc Res. 10.1093/cvr/cvr154.
2. Weskamp, G. et al. (2010). Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ. Res. 106:932-94.
3. Hirata, H. et al. (2010). Role of secreted Frizzled-related protein3 in human renal cell carcinoma. Cancer Res. 70:1896-1905.
4. Alfano, R.W. et al. (2009). Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. Mol. Cancer Res. 7:452-461.
5. Nogueras, S. et al. (2008). Coupling of endothelial injury and repair. An analysis using an in vivo experimental model. Am J. Physiol Heart Circ Physiol 294:H708-H713.
6. Masamune, A. et al. (2008). Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G709-G717.
7. Zou, L. et al. (2007). Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J. 22:355-364.